OPTIONS: A Patient-Centered HIV Prevention Decision Aid for PrEP Uptake for Women With Substance Use in Treatment Settings



Status:Recruiting
Conditions:HIV / AIDS, Psychiatric
Therapuetic Areas:Immunology / Infectious Diseases, Psychiatry / Psychology
Healthy:No
Age Range:18 - Any
Updated:1/11/2019
Start Date:October 15, 2018
End Date:June 1, 2021
Contact:Jaimie P Meyer, MD
Email:jaimie.meyer@yale.edu
Phone:203-737-6233

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Developing and Testing the Effect of a Patient-Centered HIV Prevention Decision Aid on PrEP Uptake for Women With Substance Use in Treatment Settings

To develop and test the effect of a patient-centered HIV prevention decision aid on HIV
pre-exposure prophylaxis (PrEP) uptake among women with substance use disorders (SUD) in
treatment.

To test the effect of the informed decision aid intervention on PrEP uptake among women with
substance use disorders in treatment. Investigators hypothesize that compared to those
receiving standard harm reduction information, women receiving the decision aid will have a
significant increase in PrEP uptake at 6 and 12 months post-intervention.

Inclusion Criteria:

- Self- identification as female (i.e., cis- or trans- women), age ≥18, HIV negative
status (confirmed with APT date from rapid testing procedures), and entering or
receiving treatment at our partnering site, the APT Foundation, Inc. (a drug treatment
center).

Exclusion Criteria:

- Women on PrEP at baseline, unable or unwilling to provide informed consent,
threatening to staff, pregnant, or experiencing symptoms of physiological withdrawal
that interfere with ability to provide informed consent
We found this trial at
1
site
Yale AIDS Program
New Haven, Connecticut 06510
Principal Investigator: Jaimie P Meyer, MD
Phone: 203-499-8075
?
mi
from
New Haven, CT
Click here to add this to my saved trials